ADVERTISEMENT

Advertising, Marketing & Sales

Appeals Court Clips CRN’s Constitutional Argument Against Age-Restricting Supplement Sales

Three-judge Second Circuit panel rejects CRN’s argument that New York General Business Law Section 391-oo, effective since April 2024 as first in US to prohibit sales of certain supplements to consumers under 18, violates First Amendment rights of supplement marketers.

California Firm Too Busy To Defend Ad Claims For NAD+ Supplement It Previously Marketed

Virgin Scent didn’t respond to NAD attorneys’ “repeated outreach attempts” asking for evidence supporting ad claims for Artnaturals NAD+ challenged by another NAD+ supplement marketer, Reus Research.

Weight Loss Emerging As Herbalife Protocol For Sales With Pro2Col App Launch Approaching

MultiBurn supplement launch “is creating kind of a new focus I would say around weight loss, where quite honestly, we’ve been probably more of a healthy active lifestyle,” says CEO Stephan Gratziani. Pro2Col app for personalized wellness launching before January.

Perrigo Eyes Big Decision On Formula Business Three Years After Going Big With Expansion

Perrigo pauses $240m spending planned for formula business as it considers options to be in better position to boost growth on OTC drugs. “Problems make formula manufacturing’s “long-term fit alongside our faster-growing, higher-cash-yielding consumer health OTC portfolio less strategic,” says presi

‘Standalone’ History For Kenvue All ‘Downhill’

Kenvue share price on downward trend since its highly anticipated spinout from J&J in 2023.

Kenvue Fails To Deliver After Launch Expected To Drive Iconic Brands To New Heights

Kenvue’s latest results could be a sign of things to come for other consumer health product businesses launched as spinouts from pharmaceutical giants. Along with its third-quarter results on Nov. 3, Kenvue announces deal to be acquired by Kimberly-Clark.

Consumer Health Q3 Earnings Preview: Another Trump Administration Trigger May Tip Forecasts

Other OTC marketers could join Kenvue in submitting comments opposing citizen petition request for label warnings about prenatal exposure to acetaminophen. Firms also will be discussing costs linked to tariffs Trump has imposed on imports from most every country, particularly China and India, and th

Hong Kong OTC Antifungal Pen Firm Erases Challenged US Ad Claims Without Argument

National Advertising Division says XF Agencija permanently discontinued benefits and efficacy ad claims for Lunavia undecylenic acid 25% nail pen challenged by Advantice Health, marketer of Kerasal fungal nail renewal brand.

One Plus, More Minuses In Review Of NAD+ Supplement Firm’s Advertising Claims

National Advertising Division, on challenge by NAD+ trailblazer Niagen Bioscience, found substantiation lacking for Cata-Kor NAD+ and NAD+ Core product content and health benefit claims and no clear and conspicuous disclosures for brand’s influencer posts.

FTC’s New Healthcare Division Chief Is Former Antitrust Prosecutor

Emma Mittelstaedt Burnham prosecuted antitrust violations in healthcare sector in her previous work at DoJ, including leading investigation into antitrust cartels in the generic pharmaceutical industry.

‘Super Confused’ About Nutrition And Supplements, Do US Consumers Need Dieticians For Answers?

Studies and surveys “all point to one thing, that consumers don't understand nutrition,” says marketing consultant Stephen McCauley. Registered dieticians, including some with a nutrition specialty, are strong candidates to help health and wellness firms clear up the confusion.

Nutrafol Pitches Growth With MLB As Spreading Baldness, Personalization Interest Drive Demand

Nutrafol competes for share in global hair growth in market of drug, supplement and other products estimated in one report at $7.7bn in 2023 and projected to reach nearly $11.6bn by 2030, or $25bn by 2034 according to a second report. Brand’s "Hats Off" campaign will include testimonials from baseba